{"id":12200,"date":"2024-12-20T15:15:00","date_gmt":"2024-12-20T14:15:00","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12200"},"modified":"2026-03-03T11:16:42","modified_gmt":"2026-03-03T10:16:42","slug":"medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/","title":{"rendered":"Communiqu\u00e9 de presse:  Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>Aujourd\u2019hui, le Conseil f\u00e9d\u00e9ral a conclu les n\u00e9gociations visant \u00e0 renforcer les relations bilat\u00e9rales entre la Suisse et l\u2019Union europ\u00e9enne et souligne ainsi clairement la valeur \u00e0 long terme des accords bilat\u00e9raux et leur importance cruciale pour la stabilit\u00e9 \u00e9conomique et la prosp\u00e9rit\u00e9 de la Suisse.<\/strong><\/p>\n\n\n\n<p>Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne: \u00abLa voie bilat\u00e9rale s\u2019est av\u00e9r\u00e9e \u00eatre un concept performant qui assure \u00e0 la Suisse et \u00e0 sa population prosp\u00e9rit\u00e9 et stabilit\u00e9. Nous saluons le fait que le Conseil f\u00e9d\u00e9ral ait stabilis\u00e9 aujourd\u2019hui cette voie porteuse de succ\u00e8s depuis 25&nbsp;ans et la conduise vers l\u2019avenir.\u00bb<\/p>\n\n\n\n<p>Du point de vue d\u2019Interpharma, les accords suivants rev\u00eatent une importance strat\u00e9gique:<\/p>\n\n\n\n<p><strong>L\u2019ARM simplifie les exportations de l\u2019industrie et accro\u00eet la s\u00e9curit\u00e9 d\u2019approvisionnement.<\/strong><\/p>\n\n\n\n<p>L\u2019ARM entre la Suisse et l\u2019UE \u00e9limine des obstacles techniques au commerce et permet de commercer librement avec l\u2019UE. Sans l\u2019ARM, la place pharmaceutique suisse risquerait d\u2019\u00eatre soumise \u00e0 de doubles inspections des sites de recherche et de production ainsi qu\u2019\u00e0 de nouvelles certifications des lots dans l\u2019UE. Des calculs montrent que la disparition de l\u2019ARM avec l\u2019UE entra\u00eenerait des co\u00fbts de plus de 500&nbsp;millions de francs suisses par ann\u00e9e. De nouveaux obstacles techniques au commerce risqueraient en outre de d\u00e9grader l\u2019acc\u00e8s des patient-e-s suisses \u00e0 des m\u00e9dicaments vitaux.<\/p>\n\n\n\n<p><strong>La libre circulation des personnes aide \u00e0 acc\u00e9der \u00e0 du personnel qualifi\u00e9 indispensable.<\/strong><\/p>\n\n\n\n<p>L\u2019industrie pharmaceutique a particuli\u00e8rement besoin de personnel hautement qualifi\u00e9. Sans personnel \u00e9tranger, la branche pharmaceutique ne pourrait ni faire autant de travaux de recherche, ni produire autant, car malgr\u00e9 des efforts constants de renforcer le march\u00e9 du travail national, celui-ci n\u2019est pas assez grand pour couvrir la forte demande en personnel hautement qualifi\u00e9. Pour ce qui est de la protection des salaires, le niveau actuel est durablement assur\u00e9, ce qui est un grand succ\u00e8s. D\u2019autres mesures ne sont donc pas n\u00e9cessaires, elles affaibliraient la flexibilit\u00e9 du march\u00e9 du travail.<\/p>\n\n\n\n<p>Mais il existe aussi des d\u00e9fis dont il faut tenir compte. C\u2019est ainsi que l\u2019immigration est source d\u2019incertitudes et requiert des mesures d\u2019accompagnement cibl\u00e9es pour tenir compte des besoins de la population. \u00c0 cet \u00e9gard, nous saluons le fait que le Conseil f\u00e9d\u00e9ral ait r\u00e9ussi \u00e0 int\u00e9grer dans le paquet une clause de protection. Nous attendons en outre du Conseil f\u00e9d\u00e9ral qu\u2019il pr\u00e9sente des mesures efficaces dans le domaine de la lutte contre les abus du droit d\u2019asile et continue de faire avancer l\u2019exploitation du potentiel de main-d\u2019\u0153uvre de notre pays.<\/p>\n\n\n\n<p><strong>La recherche et l\u2019innovation sont \u00e0 la base du succ\u00e8s.<\/strong><\/p>\n\n\n\n<p>Un \u00e9l\u00e9ment essentiel de la coop\u00e9ration bilat\u00e9rale est la promotion de la recherche et de l\u2019innovation. L\u2019accord de participation de la Suisse aux programmes de l\u2019UE entre en vigueur d\u00e8s sa ratification dans le cadre du paquet global. La conclusion mat\u00e9rielle des n\u00e9gociations signifie que la Commission europ\u00e9enne a proc\u00e9d\u00e9 \u00e0 l\u2019activation compl\u00e8te de l\u2019arrangement transitoire \u00e0 compter du 1<sup>er<\/sup>&nbsp;janvier 2025. Les chercheurs et innovateurs de Suisse peuvent ainsi participer \u00e0 presque tous les appels \u00e0 projets d\u2019Horizon Europe \u00e0 partir de l\u2019ann\u00e9e de programme 2025.<br><br><\/p>\n\n\n\n<p><br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aujourd\u2019hui, le Conseil f\u00e9d\u00e9ral a conclu les n\u00e9gociations visant \u00e0 renforcer les relations bilat\u00e9rales entre la Suisse et l\u2019Union europ\u00e9enne et souligne ainsi clairement la valeur \u00e0 long terme des accords bilat\u00e9raux et leur importance cruciale pour la stabilit\u00e9 \u00e9conomique et la prosp\u00e9rit\u00e9 de la Suisse. Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne: \u00abLa voie bilat\u00e9rale s\u2019est [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3149,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[120,122,130,131,141],"class_list":["post-12200","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-innovation-fr","tag-communique-de-presse","tag-pharmastandort-2030-fr","tag-politique","tag-recherche"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse\" \/>\n<meta property=\"og:description\" content=\"Aujourd\u2019hui, le Conseil f\u00e9d\u00e9ral a conclu les n\u00e9gociations visant \u00e0 renforcer les relations bilat\u00e9rales entre la Suisse et l\u2019Union europ\u00e9enne et souligne ainsi clairement la valeur \u00e0 long terme des accords bilat\u00e9raux et leur importance cruciale pour la stabilit\u00e9 \u00e9conomique et la prosp\u00e9rit\u00e9 de la Suisse. Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne: \u00abLa voie bilat\u00e9rale s\u2019est [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-20T14:15:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T10:16:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse\",\"datePublished\":\"2024-12-20T14:15:00+00:00\",\"dateModified\":\"2026-03-03T10:16:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\"},\"wordCount\":597,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"keywords\":[\"Innovation\",\"Communiqu\u00e9 de presse\",\"Pharmastandort 2030\",\"Politique\",\"Recherche\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\",\"name\":\"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"datePublished\":\"2024-12-20T14:15:00+00:00\",\"dateModified\":\"2026-03-03T10:16:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg\",\"width\":2560,\"height\":1731},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse","og_description":"Aujourd\u2019hui, le Conseil f\u00e9d\u00e9ral a conclu les n\u00e9gociations visant \u00e0 renforcer les relations bilat\u00e9rales entre la Suisse et l\u2019Union europ\u00e9enne et souligne ainsi clairement la valeur \u00e0 long terme des accords bilat\u00e9raux et leur importance cruciale pour la stabilit\u00e9 \u00e9conomique et la prosp\u00e9rit\u00e9 de la Suisse. Ren\u00e9 Buholzer, directeur d\u2019Interpharma, souligne: \u00abLa voie bilat\u00e9rale s\u2019est [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/","og_site_name":"Interpharma","article_published_time":"2024-12-20T14:15:00+00:00","article_modified_time":"2026-03-03T10:16:42+00:00","og_image":[{"width":2560,"height":1731,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse","datePublished":"2024-12-20T14:15:00+00:00","dateModified":"2026-03-03T10:16:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/"},"wordCount":597,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","keywords":["Innovation","Communiqu\u00e9 de presse","Pharmastandort 2030","Politique","Recherche"],"inLanguage":"fr-FR","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/","name":"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","datePublished":"2024-12-20T14:15:00+00:00","dateModified":"2026-03-03T10:16:42+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/03\/CH_EU_generisch-klein-scaled.jpg","width":2560,"height":1731},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-verhandlungsabschluss-zu-den-bilateralen-iii-ein-wichtiger-schritt-fuer-die-sicherung-von-wohlstand-und-innovationskraft-der-schweiz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Conclusion des n\u00e9gociations sur les accords bilat\u00e9raux III: une \u00e9tape importante pour maintenir la prosp\u00e9rit\u00e9 et la force d\u2019innovation de la Suisse"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12200"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12200\/revisions"}],"predecessor-version":[{"id":12201,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12200\/revisions\/12201"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3149"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12200"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}